City

Milano (1)

Tianjin (1)

Condition

Measurable Disease (2)

Acute Myeloid Leukemia (1)

Germ Cell Tumors (1)

Overall Status

Completed (1)

Recruiting (1)

Sign in for free

Phase

phase 2 (2)

Sponsor

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano (1)

Institute of Hematology & Blood Diseases Hospital (1)

Collaborator

GlaxoSmithKline (1)

Intervention

pazopanib (1)

venetoclax, azacitidine (1)

venetoclax, daunorubicin, cytarabine (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Other (2)

Study Type

Interventional (2)

measurable disease

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Acute Myeloid Leukemia, Measurable Disease Trial in Tianjin (Venetoclax, Azacitidine, Venetoclax, daunorubicin, cytarabine)

Recruiting

Acute Myeloid Leukemia
Measurable Disease

Venetoclax, Azacitidine
Venetoclax, daunorubicin, cytarabine

Tianjin, Tianjin, China

HBDH

Apr 28, 2022

Germ Cell Tumors, Measurable Disease Trial in Milano (Pazopanib)

Completed

Germ Cell Tumors
Measurable Disease

Pazopanib

Milano, Mi, Italy

Fondazione IRCCS Istituto Nazionale dei Tumori

May 12, 2021